http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100425030-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-808 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-085 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-085 |
| filingDate | 2003-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100425030-B1 |
| titleOfInvention | Novel anti-viral VSF protein and hybridoma producing the same |
| abstract | The present invention provides a VSF (Virus Suppressing Factor) protein with novel antiviral activity and a hybridoma secreting the same. The present invention also provides a pharmaceutical composition for preventing or treating an infectious disease in humans and animals caused by a virus comprising the protein, and a method for preventing or treating a viral infectious disease using the composition. The VSF protein according to the present invention has potent antiviral activity against various kinds of viruses. |
| priorityDate | 2002-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 536.